Top news of the week: 08.06.2021.
Healthcare
Constellation Pharma Shares Sparkle on $1.7 Billion Buyout Offer
Shares of Constellation Pharmaceuticals Inc. traded 65% higher after the company reported it entered into an agreement to be acquired by MorphoSys AG in an all-cash transaction for $34 per ...
Biotech Receives National Cancer Institute Resources Award for Ovarian Cancer Vaccine Program Research Report
The award and other recent developments at Anixa Biosciences are covered in an H.C. Wainwright & Co. report.
Biotech Firm Confirms 100% Accuracy of COVID-19 Mutation Assays
Applied DNA Sciences' SARS-CoV-2 mutation panel and its validation are discussed in a ROTH Capital Partners report.
Will you accept this capital investment? Biotech and health startups bet on a strange new reality show for crowdfunding
A panel of judges that includes former NSYNC band member Lance Bass debate, on air, whether to invest in biotech and health startups.
Listen: Fauci’s emails, FDA kremlinology, & covering the CRISPR babies scandal
In this episode, we discuss why it's so hard to predict FDA decisions, and why the latest big deal in biotech left investors cold.
SELECTION study on filgotinib in ulcerative colitis published in The Lancet
Mechelen, Belgium; 4 June 2021; 07.01 CET; – Galapagos NV (Euronext & Nasdaq: GLPG) today announced that primary and secondary endpoint results from...
The Dementia Discovery Fund welcomes FDA’s approval of aducanumab for Alzheimer’s disease
The Dementia Discovery Fund (DDF), the venture capital fund investing in, and creating, biotech companies pursuing transformational therapeutic approaches for dementias, welcomes …
MorphoSys and Incyte Announce Three-Year Results from Phase 2 L-MIND Study of Tafasitamab in Combination with Lenalidomide for the Treatment of Relapsed or Refractory DLBCL
Media Release MorphoSys and Incyte Announce Three-Year Results from Phase 2 L-MIND Study of Tafasitamab in Combination with Lenalidomide for the Treatment of Relapsed or …